TEVA
TEVA clinical trials: TEVA PHARMACEUTICAL INDUSTRIES LTD
Every trial on ClinicalTrials.gov where TEVA PHARMACEUTICAL INDUSTRIES LTD is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 18
- Trials linked
- 4
- As lead sponsor
- 14
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
TEVA on the catalyst calendar · TEVA registry changes
- Primary completion Jun 17, 2008ActualPhase 2NCT00326625Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)Teva Pharmaceutical Industries, Ltd. · Amyotrophic Lateral SclerosisCompletedTEVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 30, 2016ActualPhase 2NCT02092077A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient ChildrenTeva Pharmaceutical Industries, Ltd. · Growth Hormone-DeficiencyTerminatedTEVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 23, 2012ActualPhase 1NCT01123070TL011 in Severe, Active Rheumatoid Arthritis PatientsTeva Pharmaceutical Industries, Ltd. · Rheumatoid ArthritisCompletedTEVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 23, 2017ActualPhase 2NCT00745615An Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the DiseaseTeva Pharmaceutical Industries, Ltd. · Relapsing Remitting Multiple SclerosisTerminatedTEVALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 1, 2020ActualPhase 3NCT02683239Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or HipRegeneron Pharmaceuticals · Osteoarthritis of the Knee or HipCompletedREGNLeadTEVACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 25, 2020ActualPhase 2NCT03949673Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and HipRegeneron Pharmaceuticals · Osteoarthritis, KneeTerminatedREGNLeadTEVACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 28, 2023ActualPhase 1NCT05532358A Drug-Drug Interaction Study to Assess the CYP1A2 and CYP3A4 Interaction Potential of TEV-56286 (anle138b)MODAG GmbH · Healthy VolunteersCompletedTEVACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 30, 2020ActualPhase 2NCT03691974Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients With Pain Due to Osteoarthritis of the Hip or KneeRegeneron Pharmaceuticals · Osteoarthritis, KneeCompletedREGNLeadTEVACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 13, 2019ActualPhase 3NCT03304379Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for...Regeneron Pharmaceuticals · Osteoarthritis, KneeCompletedREGNLeadTEVACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 9, 2019ActualPhase 3NCT03161093A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From...Regeneron Pharmaceuticals · Osteoarthritis, KneeCompletedREGNLeadTEVACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 8, 2020ActualPhase 2NCT04358068Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19National Institute of Allergy and Infectious Diseases (NIAID) · COVID-19TerminatedTEVACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 5, 2018ActualPhase 3NCT03285646Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or...Regeneron Pharmaceuticals · Chronic Low Back PainTerminatedREGNLeadTEVACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 15, 2020ActualPhase 1NCT03491904To Assess the Patients' Ability to Self-Administer FasinumabRegeneron Pharmaceuticals · Osteoarthritis, KneeCompletedREGNLeadTEVACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2016ActualNo phase registeredNCT02907723Feasibility of Continuous Sleep Recording in Patients Undergoing Deep Brain Stimulation for Parkinson's DiseaseFondation Ophtalmologique Adolphe de Rothschild · Parkinson DiseaseCompletedTEVACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2015ActualNo phase registeredNCT02552303The Treatment of Insomnia Comorbid With Sleep Disordered Breathing Using Armodafinil and/or Cognitive Behavioral Therapy for InsomniaUniversity of Pennsylvania · Sleep ApneaCompletedTEVACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2018Sponsor estimatePhase 1/Phase 2NCT02835794A Clinical Trial of Omacetaxine, Azacitidine, and Growth-Colony Stimulating Factor (G-CSF) for Myelodysplastic Syndromes (MDS)University of Florida · Myelodysplastic SyndromesWithdrawnTEVACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2017Sponsor estimateNo phase registeredNCT02515643Contribution of Renal Function to Endothelial Dysfunction in Living Kidney Donors and Transplant RecipientsHospital Universitari Vall d'Hebron Research Institute · Disorder Related to Renal TransplantationUnknown statusTEVACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2015ActualPhase 2NCT02029417Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaRoswell Park Cancer Institute · Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeTerminatedTEVACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 18 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner